XML 12 R3.htm IDEA: XBRL DOCUMENT v3.23.2Close
Condensed Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Revenues:        
Premiums $ 72,474 $ 63,896 $ 145,260 $ 127,966
Investment and other income 1,115 295 1,913 662
Total revenues 92,903 80,332 184,834 160,481 Close
Operating costs:        
Medical costs 60,268 52,093 120,113 104,616
Operating costs 13,809 11,709 27,434 23,110
Cost of products sold 9,748 8,596 19,153 17,083
Depreciation and amortization 1,021 802 1,991 1,590
Total operating costs 84,846 73,200 168,691 146,399
Earnings from operations 8,057 7,132 16,143 14,082
Interest expense (828) (467) (1,582) (900) Close
Earnings before income taxes 7,229 6,665 14,561 13,182 Close
Provision for income taxes (1,572) (1,466) (3,130) (2,835) Close
Net earnings 5,657 5,199 11,431 10,347 Close
Earnings attributable to noncontrolling interests (183) (129) (346) (250) Close
Net earnings attributable to UnitedHealth Group common shareholders $ 5,474 $ 5,070 $ 11,085 $ 10,097
Earnings per share attributable to UnitedHealth Group common shareholders:        
Basic $ 5.89 $ 5.41 $ 11.91 $ 10.75
Diluted $ 5.82 $ 5.34 $ 11.77 $ 10.61
Basic weighted-average number of common shares outstanding 930 937 931 939
Dilutive effect of common share equivalents 10 13 11 13
Diluted weighted-average number of common shares outstanding 940 950 942 952
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents 7 3 6 3
Products        
Revenue from Products and Services $ 10,651 $ 9,496 $ 20,918 $ 18,836
Services        
Revenue from Products and Services $ 8,663 $ 6,645 $ 16,743 $ 13,017